Office of the Registrar or Lobbying of BC

Menus

  • Menus

www.lobbyistsregistrar.bc.ca

  • www.lobbyistsregistrar.bc.ca

Designated Filer menu

  • Registry Search Tools
    • 12-Month Lobbying Activity Search
    • Advanced Registry Search
  • Reporting Tools
    • Recent Registrations
    • Recent Lobbying Activity Reports by Posted Date
    • Government Funding Report
    • Gifts to Public Office Holders Report
    • Listing of All Lobbyists and Senior Officers
    • Listing of Senior Public Officer Holders who are in Lobbying Activity Reports
    • Listing of Organizations Clients and their Direct Interests
  • Lobbying Statistics
    • Active Lobbyists and Registrations by Type
    • Ministries/Provincial Entities in Active Registrations
    • Ministries/Provincial Entities in Lobbying Activity Reports
    • Lobbying Activity Reports by Reporting Period
    • Subject Matter in Active Registrations
    • Subject Matter in Lobbying Activity Reports
    • Intended Outcomes in Active Registrations
    • Intended Outcomes in Lobbying Activity Reports
  • Help
    • LTA Guidance Documents
    • Using the Registry
    • Legislation
    • LTA Frequently Asked Questions
    • Contact Us
  • Sign In

You are here:

  1. Registry Dashboard

 

Subject matter details

MERCK CANADA INC.


Registration: 40 of 41 (2025-07-11 to 2025-10-17)

Details Regarding the Identified Subject Matter
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Communicate with BC government about conditions under which innovative drugs and vaccines are marketed and reimbursed in BC, including under the BC Drug Plans or under federal legislation. In particular, communicating to emphasize the importance that federal and provincial governments respect their respective jurisdiction for approval of marketing and reimbursement of drugs.
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity
Health
Communicate with BC government to leverage BC programs and related resources/tools as a best practice in other markets.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health
Communicate with BC government to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs and vaccines.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
Health
Discuss legislation enacted or proposed to ensure that innovative drugs are excluded from the tendering process covered by such legislation until the expiry of the period covered by their patents.
Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity
Health
Engage BC government on Merck’s commercial product/asset pipeline and seek access listing agreements.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
Health
Seeking recommendation for Merck vaccine product through Immunization and Vaccine Preventable Disease Service Program under the Provincial Health Services Authority.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health